FR2362636A1 - THERAPEUTIC COMPOSITION FOR THE TREATMENT OF HYPERTENSION CONDITIONS - Google Patents

THERAPEUTIC COMPOSITION FOR THE TREATMENT OF HYPERTENSION CONDITIONS

Info

Publication number
FR2362636A1
FR2362636A1 FR7725671A FR7725671A FR2362636A1 FR 2362636 A1 FR2362636 A1 FR 2362636A1 FR 7725671 A FR7725671 A FR 7725671A FR 7725671 A FR7725671 A FR 7725671A FR 2362636 A1 FR2362636 A1 FR 2362636A1
Authority
FR
France
Prior art keywords
therapeutic composition
treatment
dose
beta
hypertension conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7725671A
Other languages
French (fr)
Other versions
FR2362636B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roehm Pharma GmbH
Original Assignee
Roehm Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roehm Pharma GmbH filed Critical Roehm Pharma GmbH
Publication of FR2362636A1 publication Critical patent/FR2362636A1/en
Application granted granted Critical
Publication of FR2362636B1 publication Critical patent/FR2362636B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La composition contient au moins un bloquant de bêta-récepteur à une dose suffisante pour maintenir l'effet de blocage sur les bêta-récepteurs et un diurétique épargnant le potassium à une dose inférieure à la dose normale, avec les véhicules et produits auxiliaires usuels. Comparativement à la monothérapie, cette composition thérapeutique provoque un taux de réponse nettement accru sur la pression sanguine, ce qui constitue un progrès important.The composition contains at least one beta-receptor blocker at a dose sufficient to maintain the blocking effect on beta-receptors and a potassium-sparing diuretic at a dose below the normal dose, with the usual vehicles and auxiliary products. Compared to monotherapy, this therapeutic composition causes a markedly increased response rate on blood pressure, which is a significant advance.

FR7725671A 1976-08-27 1977-08-23 THERAPEUTIC COMPOSITION FOR THE TREATMENT OF HYPERTENSION CONDITIONS Granted FR2362636A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762638716 DE2638716A1 (en) 1976-08-27 1976-08-27 ANTIHYPERTENSIVA

Publications (2)

Publication Number Publication Date
FR2362636A1 true FR2362636A1 (en) 1978-03-24
FR2362636B1 FR2362636B1 (en) 1980-12-05

Family

ID=5986558

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7725671A Granted FR2362636A1 (en) 1976-08-27 1977-08-23 THERAPEUTIC COMPOSITION FOR THE TREATMENT OF HYPERTENSION CONDITIONS

Country Status (4)

Country Link
JP (1) JPS5350340A (en)
DE (1) DE2638716A1 (en)
FR (1) FR2362636A1 (en)
GB (1) GB1584089A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0022330B1 (en) * 1979-07-10 1983-12-21 Smithkline Beckman Corporation Synergistic antihypertensive compositions
DE3016818A1 (en) * 1980-05-02 1982-02-04 Röhm Pharma GmbH, 6100 Darmstadt DIAGNOSTIC METHOD FOR DETERMINING THE LIVER FUNCTION
DE3025367A1 (en) * 1980-07-04 1982-01-28 Hoechst Ag, 6000 Frankfurt SALT FROM FUROSEMIDE OR PIRETANIDE AS ACIDIC COMPONENT AND PENBUTOLOL OR (-) - 3- (4- (3- (3,4-DIMETHOXYPHENYLAETHYLAMINO) -2-HYDROXY-PROPOXY) -PHENYL) -CROTONSAEURENESINESESSENESE DIESELESSENESE ALSINE DIESE ALSINE DIESE ALSINE DIESE ALENESE, DIONESE, DIONESE, DIESE, INC CONTAINING AGENT AND ITS USE
DE3172458D1 (en) * 1981-12-08 1985-10-31 Smithkline Beckman Corp Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
NL8600137A (en) * 1985-02-05 1986-09-01 Sandoz Ag PHARMACEUTICAL PREPARATIONS CONTAINING, WHEN DESIRED, COMBINED WITH 3-AMINOPROPOXYINDOLS DIURETICALLY AND METHODS FOR USING THESE PREPARATIONS.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT336176B (en) 1971-12-10 1977-04-25 Sandoz Ag METHOD FOR MANUFACTURING A PHARMACEUTICAL PREPARATION

Also Published As

Publication number Publication date
JPS5350340A (en) 1978-05-08
GB1584089A (en) 1981-02-04
DE2638716A1 (en) 1978-03-02
FR2362636B1 (en) 1980-12-05

Similar Documents

Publication Publication Date Title
FR2362636A1 (en) THERAPEUTIC COMPOSITION FOR THE TREATMENT OF HYPERTENSION CONDITIONS
Mathew Clinical subtypes of cluster headache and response to lithium therapy
KR890012644A (en) Liver Disorder Remedy
FR2397682A1 (en) METHOD AND DEVICE FOR THE CONSTRUCTION OF AN IMAGE BY TOMOGRAPHY
JPS5776220A (en) Muffler
GB1473078A (en)
Nolan Acute suicidal depression associated with use of timolol
JPS5714589A (en) Benzothiazine derivative, its preparation and drug composition
FR2329010A1 (en) PRESSURE REDUCING DEVICE WITH DIRECT STABILIZATION OF REDUCED DOWNSTREAM PRESSURE
FR2387975A1 (en) NEW PROSTACYCLINE ANALOGUES AND THEIR PREPARATION
FR2358837A1 (en) MIXTURE CONTAINING AN ANTIBIOTIC AND ENZYMES, FOR LIVESTOCK
FR2340082A1 (en) Snoring prevention device for night use - has curved plate with projections to keep constant distance between wearers jaws
Vandenbroucke Oral contraceptives and the risk of rheumatoid arthritis: the great transatlantic divide?
GB1304978A (en)
USD225448S (en) Lighter
JPS55113721A (en) Immunity regulator
FR2403820A1 (en) PROCESS FOR INTRODUCING THE GAS TO BE TREATED IN A TOURBILLON TUBE
USD163936S (en) De marzi
USD231727S (en) Robert c
USD151525S (en) Combined fireplace screen and fender
FR2097045A1 (en) 17-ethynylgon-4-en-3-ones - with progestomimetic activity useful as contraceptives and for gynaecological disorders
USD202312S (en) Combination aircraft
USD224828S (en)
USD219255S (en) Jacket
USD167275S (en) Pendant cross